博利康尼联合布地奈德雾化吸入治疗喘息性支气管炎的临床疗效研究.pdfVIP

l 临床医学鄙 2016 J_12JJ 博利康尼联合布地奈德雾化吸入治疗喘息性支气管炎的 l临床疗效研究 杨傣红 1 ，魏小姊 2 (1.西安济仁医院，陕西西安， 710302; 2. 西安市中心医院，陕西西安， 71∞03) 摘要:自由串分析博利康尼联合布地奈德雾化吸入治疗喘息性支气管炎的临床效果。古~a.将本院 2013 年 1 月至 2015 年 12 月收治的 468 例喘息性支气管炎患儿作为研究对象，按照住院顺序分成对照组和研究组，各234 例。对照纽患儿给予博利康 尼溶液雾化吸入治疗，研究纽患儿给予布地奈德混悬液联合博利康尼溶液雾化吸入治疗，比较两组患儿的临床治疗效果、不 良反应情况及住院时间。结研究组治疗总有效率(96.15%)明显高于对照纽(85.04%) ，差异具有统计学意义(P0.05) ; 研 究组不良反应发生率为 5.56% ，对照组为 15.81% ，纽间比较差异具有统计学意义(P0.05); 研究组住院时间明显短于对照纽 (P0.05) 。给俗博利康尼联合布地奈德、雾化吸入治疗喘息性支气管炎的临床效果良好，可提高患儿临床治疗效果，减少不 良反应的发生，缩短患儿住院时间，值得临床大力推广应用。 关键词:博利康尼;布地奈德;喘息性支气管炎 申固分类号:R726.5 文献标志码:A 文章编号:2096-1413(2016)25-∞30-02 Research on the clinical efficacy of bricanyl combined with budesonide inhalation in the treatment of asthmatic bronchitis YANG Dai-hong 1, WEI Xiao-di 2 (1. Xian Jiren Hospital , Xian 710302; 2. Xi an Central Hospital , Xian 71∞03， China) ABSTRACT: Objective To analyze the clinical efficacy of bricanyl combined with budesonide inhalation in the treatment of asthmatic bronchitis. Methods Four hundred and sixty-eight cases of children with asthmatic bronchitis admitted in our hospital from January 2013 to December 2015 were selected as research objecis. According to the order of hospitalization , patients were divided into control group and study group, with 234 cases in each group. The control group was given bricanyl inhalation therapy , while the study group was given budesonide combined with bricanyl inhalation therapy. The clinical treatment effect , adverse reaction and hospitalization time between the two groups w